NEW YORK (GenomeWeb) – Multiple copies of the tumor suppressor gene TP53 appear to play a role in lower rates of cancer development in elephants, according to a new study led by Joshua Schiffman of the University of Utah School of Medicine.

The results, published today in the Journal  of the American Medical Association, may also have potential to provide a better understanding of the suppression (or promotion) of cancer in humans, according to Schiffman and his colleagues.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.